Avisa Diagnostics Begins Trading on the Canadian Securities Exchange
. - Public Listing offers Access to CAD 52 Million from Share Subscription and Drawdown Agreement, Sufficient Funding to…
. - Public Listing offers Access to CAD 52 Million from Share Subscription and Drawdown Agreement, Sufficient Funding to…
Paving the way for admission to standard care in Germany High savings potential for health insurances and the health sec…
Weg zur Aufnahme in die Regelversorgung in Deutschland geebnet Hohe Einsparpotenziale für Krankenkassen und den Gesundhe…
Higher Vitamin D levels, starting from a minimum dose of 4000 international units per day (4000 IU/d, or 100 μg/d), help…
. - Avelox® erreicht primären Wirksamkeitsendpunkt der Nicht-Unterlegenheit in der gesamten Studienpopulation - Deutl…
. - Roflumilast is the first oral anti-inflammatory treatment for COPD patients, and has been developed by Nycomed - T…
With the new all-rounder for extrapulmonary lung support Novalung GmbH is the only company worldwide offering the comple…
Novalung GmbH, the German manufacturer of the world's leading therapeutic system for extrapulmonary lung support, has si…
. - Forest Laboratories acquires exclusive commercialisation rights to Daxas® in the United States in treatment of symp…
. - New drug application filed for United States - Treatment aimed at patients with symptomatic Chronic Obstructive Pu…